WithdrawnNot Applicable

Treatment of Rotator Cuff Tears With Platelet Rich Plasma

Stopped: Use of PRP does not require a registered clinical trial

United States0Started 2015-01-23

Plain-language summary

The purpose of this study is to evaluate the safety and effectiveness of dual platelet rich plasma (PRP) injections into the rotator cuff insertion and the area of the tendon proximal to the insertion.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Rotator cuff pathology established by exam * Rotator cuff pathology confirmed with MRI. * Failure to improve with activity modification and physical therapy * Willingness to stop all NSAID medication Exclusion Criteria: * Additional significant shoulder pathology seen on xray or MRI including: severe arthritis, significant superior labrum anterior postierior (SLAP) Type II lesions and intra-articular loose bodies. * Shoulder surgery within 6 months. * Presence of full thickness rotator cuff tears in patients amenable to surgical repair.

What they're measuring

Quick Disabilities of the Arm, Shoulder and Hand Score (Quick-DASH)

Timeframe: change from baseline to 6 months

Quick Disabilities of the Arm, Shoulder and Hand Score (Quick-DASH)

Timeframe: change from baseline to 12 months

Quick Disabilities of the Arm, Shoulder and Hand Score (Quick-DASH)

Timeframe: change from baseline to 24 months

Trial details

NCT IDNCT06481046

SponsorThe Foundation for Orthopaedics and Regenerative Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-01-25

View on ClinicalTrials.gov More Rotator Cuff Tears trials